hydralazine and Tachycardia
hydralazine has been researched along with Tachycardia in 23 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"To assess the electrophysiological and antiarrhythmic effects of pharmacological load manipulation by an angiotensin converting enzyme (ACE) inhibitor (captopril) and a direct vasodilator (hydralazine plus isosorbide mononitrate) in patients with inducible ventricular tachycardia and impaired left ventricular function." | 9.07 | Comparative electrophysiological effects of captopril or hydralazine combined with nitrate in patients with left ventricular dysfunction and inducible ventricular tachycardia. ( Bashir, Y; Camm, AJ; Gibson, S; O'Nunain, S; Paul, VE; Sneddon, JF; Ward, DE, 1992) |
"The antihypertensive efficacy and safety of IV labetalol were evaluated and compared with the efficacy and safety of IV hydralazine in the treatment of postoperative hypertension." | 9.06 | Comparative hemodynamic effects of labetalol and hydralazine in the treatment of postoperative hypertension. ( Dimich, I; Gabrielson, G; Kaplan, JA; Lingham, R; Singh, PP, 1989) |
"This study aims to characterize the development of tachycardia after intravenous hydralazine administration during Phase I recovery." | 7.88 | Incidence, Course, and Characteristics of Hydralazine-Associated Tachycardia During Phase I Postanesthesia Recovery. ( Loken, BL; Oyen, LJ; Sebesta, HM; Shirk Marienau, M; Smith, JL; Sprung, J; Weingarten, TN, 2018) |
"The role of the sympatho-adrenal system in the production of tachycardia accompanying the hypotensive response to hydralazine was studied in urethane-anesthetized rats subjected to previous bilateral adrenal demedullation or to pretreatment with 6-hydroxydopamine and compared with intact control animals." | 7.67 | Role of the sympatho-adrenal system in the reflex tachycardia produced by hydralazine in the anesthetized rat. ( García-Márquez, F; Vidrio, H, 1986) |
"Supine and upright hemodynamic measurements were performed in 10 patients with chronic congestive heart failure, before and during vasodilator therapy with hydralazine and isosorbide dinitrate." | 7.66 | Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure. ( Haughom, F; Kramer, B; Massie, B, 1981) |
"The correlation between hydralazine-induced tachycardia and overall cardiovascular reactivity to sympathetic stimulation was explored in 50 normal subjects." | 7.66 | Hydralazine tachycardia and sympathetic cardiovascular reactivity in normal subjects. ( Tena, I; Vidrio, H, 1980) |
"Severe tachycardia, ventricular ectopy, and sodium retention manifested by hemodynamic deterioration developed with hydralazine hydrochloride therapy in chronic coronary heart disease with congestive failure refractory to digitalis, diuretics, and nitrates." | 7.66 | Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy. ( Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT, 1978) |
"Treatment with procainamide not only inhibited the overexpression of DNMT1 but also diminished the overproduction of IL-6 in rhabdomyolysis rats." | 5.43 | Therapeutic Effects of Procainamide on Endotoxin-Induced Rhabdomyolysis in Rats. ( Chen, SJ; Hii, HP; Ka, SM; Liao, MH; Shih, CC; Tsao, CM; Wu, CC, 2016) |
"Propranolol was demonstrated to block hydralazine-induced increases in serum renin activity in genetically hypertensive rats." | 5.25 | Altered renin release and propranolol potentiation of vasodilatory drug hypotension. ( Keeton, K; Pettinger, WA, 1975) |
"To assess the electrophysiological and antiarrhythmic effects of pharmacological load manipulation by an angiotensin converting enzyme (ACE) inhibitor (captopril) and a direct vasodilator (hydralazine plus isosorbide mononitrate) in patients with inducible ventricular tachycardia and impaired left ventricular function." | 5.07 | Comparative electrophysiological effects of captopril or hydralazine combined with nitrate in patients with left ventricular dysfunction and inducible ventricular tachycardia. ( Bashir, Y; Camm, AJ; Gibson, S; O'Nunain, S; Paul, VE; Sneddon, JF; Ward, DE, 1992) |
"The antihypertensive efficacy and safety of IV labetalol were evaluated and compared with the efficacy and safety of IV hydralazine in the treatment of postoperative hypertension." | 5.06 | Comparative hemodynamic effects of labetalol and hydralazine in the treatment of postoperative hypertension. ( Dimich, I; Gabrielson, G; Kaplan, JA; Lingham, R; Singh, PP, 1989) |
"The present evidence suggests similar efficacy between nifedipine, hydralazine and labetalol in the treatment of severe hypertension in pregnancy." | 4.98 | Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials. ( Sequeira, RP; Sridharan, K, 2018) |
"This study aims to characterize the development of tachycardia after intravenous hydralazine administration during Phase I recovery." | 3.88 | Incidence, Course, and Characteristics of Hydralazine-Associated Tachycardia During Phase I Postanesthesia Recovery. ( Loken, BL; Oyen, LJ; Sebesta, HM; Shirk Marienau, M; Smith, JL; Sprung, J; Weingarten, TN, 2018) |
"Azelnidipine suppressed cardiac hypertrophy, fibrosis, NADPH oxidase and superoxide in spSHRs more potently than amlodipine, and was associated with lower heart rates than amlodipine." | 3.73 | Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis. ( Ito, T; Kataoka, K; Kim-Mitsuyama, S; Lai, ZF; Ogawa, H; Tanaka, T; Tokutomi, Y; Yamamoto, E; Yamashita, T, 2006) |
"Hydralazine (H) induces hypotension accompanied by cardiac stimulation due to activation of the arterial baroreflex." | 3.69 | Patterns of heart rate responses to hydralazine in normotensive and hypertensive rats. ( Vidrio, H, 1996) |
"The role of the sympatho-adrenal system in the production of tachycardia accompanying the hypotensive response to hydralazine was studied in urethane-anesthetized rats subjected to previous bilateral adrenal demedullation or to pretreatment with 6-hydroxydopamine and compared with intact control animals." | 3.67 | Role of the sympatho-adrenal system in the reflex tachycardia produced by hydralazine in the anesthetized rat. ( García-Márquez, F; Vidrio, H, 1986) |
"Supine and upright hemodynamic measurements were performed in 10 patients with chronic congestive heart failure, before and during vasodilator therapy with hydralazine and isosorbide dinitrate." | 3.66 | Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure. ( Haughom, F; Kramer, B; Massie, B, 1981) |
"The correlation between hydralazine-induced tachycardia and overall cardiovascular reactivity to sympathetic stimulation was explored in 50 normal subjects." | 3.66 | Hydralazine tachycardia and sympathetic cardiovascular reactivity in normal subjects. ( Tena, I; Vidrio, H, 1980) |
"Severe tachycardia, ventricular ectopy, and sodium retention manifested by hemodynamic deterioration developed with hydralazine hydrochloride therapy in chronic coronary heart disease with congestive failure refractory to digitalis, diuretics, and nitrates." | 3.66 | Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy. ( Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT, 1978) |
"Treatment with procainamide not only inhibited the overexpression of DNMT1 but also diminished the overproduction of IL-6 in rhabdomyolysis rats." | 1.43 | Therapeutic Effects of Procainamide on Endotoxin-Induced Rhabdomyolysis in Rats. ( Chen, SJ; Hii, HP; Ka, SM; Liao, MH; Shih, CC; Tsao, CM; Wu, CC, 2016) |
"Propranolol was demonstrated to block hydralazine-induced increases in serum renin activity in genetically hypertensive rats." | 1.25 | Altered renin release and propranolol potentiation of vasodilatory drug hypotension. ( Keeton, K; Pettinger, WA, 1975) |
Research
Studies (23)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (65.22) | 18.7374 |
1990's | 3 (13.04) | 18.2507 |
2000's | 1 (4.35) | 29.6817 |
2010's | 4 (17.39) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Sridharan, K | 1 |
Sequeira, RP | 1 |
Weingarten, TN | 1 |
Loken, BL | 1 |
Smith, JL | 1 |
Sebesta, HM | 1 |
Shirk Marienau, M | 1 |
Oyen, LJ | 1 |
Sprung, J | 1 |
Shih, CC | 1 |
Hii, HP | 1 |
Tsao, CM | 1 |
Chen, SJ | 1 |
Ka, SM | 1 |
Liao, MH | 1 |
Wu, CC | 1 |
Cohn, JN | 1 |
McInnes, GT | 1 |
Shepherd, AM | 1 |
Yamamoto, E | 1 |
Lai, ZF | 1 |
Yamashita, T | 1 |
Tanaka, T | 1 |
Kataoka, K | 1 |
Tokutomi, Y | 1 |
Ito, T | 1 |
Ogawa, H | 1 |
Kim-Mitsuyama, S | 1 |
Kubo, T | 1 |
Yamashita, M | 1 |
Misu, Y | 1 |
Massie, B | 1 |
Kramer, B | 1 |
Haughom, F | 1 |
Heer, KR | 1 |
Davies, J | 1 |
MacArthur, CG | 1 |
Vidrio, H | 3 |
Tena, I | 1 |
Pettinger, WA | 1 |
Keeton, K | 1 |
Penhall, RK | 1 |
Frewin, DB | 1 |
Laslett, LJ | 1 |
DeMaria, AN | 1 |
Amsterdam, EA | 1 |
Mason, DT | 1 |
Munoz, AI | 1 |
Baralt, JF | 1 |
Melendez, MT | 1 |
Bashir, Y | 1 |
Sneddon, JF | 1 |
O'Nunain, S | 1 |
Paul, VE | 1 |
Gibson, S | 1 |
Ward, DE | 1 |
Camm, AJ | 1 |
Farker, K | 1 |
Henschel, L | 1 |
Marschner, JP | 1 |
Reimann, I | 1 |
Volkmann, H | 1 |
Hoffmann, A | 1 |
Dimich, I | 1 |
Lingham, R | 1 |
Gabrielson, G | 1 |
Singh, PP | 1 |
Kaplan, JA | 1 |
García-Márquez, F | 1 |
Belic, N | 1 |
Talano, JV | 1 |
Lagrue, G | 1 |
Weil, B | 1 |
Buisson, C | 1 |
Katila, M | 1 |
Frick, MH | 1 |
Gupta, KP | 1 |
Bhargava, KP | 1 |
Demers, L | 1 |
Gauthier, P | 1 |
Reviews
2 reviews available for hydralazine and Tachycardia
Article | Year |
---|---|
Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Topics: Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Headache; Humans; Hydralazine; Hy | 2018 |
Direct-acting vasodilators.
Topics: Antihypertensive Agents; Hirsutism; Humans; Hydralazine; Hypertension; Minoxidil; Tachycardia; Treat | 2011 |
Trials
3 trials available for hydralazine and Tachycardia
Article | Year |
---|---|
Comparative electrophysiological effects of captopril or hydralazine combined with nitrate in patients with left ventricular dysfunction and inducible ventricular tachycardia.
Topics: Aged; Captopril; Drug Combinations; Electrocardiography; Electrophysiology; Female; Heart; Hemodynam | 1992 |
Comparative hemodynamic effects of labetalol and hydralazine in the treatment of postoperative hypertension.
Topics: Aged; Female; Hemodynamics; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Postope | 1989 |
Combined dihydralazine and propranolol in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Guanidines; Humans; Hydralazine; Hype | 1970 |
Other Studies
18 other studies available for hydralazine and Tachycardia
Article | Year |
---|---|
Incidence, Course, and Characteristics of Hydralazine-Associated Tachycardia During Phase I Postanesthesia Recovery.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anesthesia Recovery Period; Antihypertensive Agents; Fe | 2018 |
Therapeutic Effects of Procainamide on Endotoxin-Induced Rhabdomyolysis in Rats.
Topics: Acidosis; Animals; Bicarbonates; Biomarkers; Creatinine; DNA (Cytosine-5-)-Methyltransferase 1; DNA | 2016 |
Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis.
Topics: Amlodipine; Animals; Azetidinecarboxylic Acid; Cardiomegaly; Dihydropyridines; Endomyocardial Fibros | 2006 |
Effects of beta blocking agents on the cardiovascular action of hydralazine in conscious rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Heart Rate; Hydralazine; Male; Rats; Rats, Inb | 1981 |
Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Hydralazine; Hypotension, Orthostatic; Isosorbide Dinitrate; Lo | 1981 |
The effect of hydralazine on arrhythmias in congestive cardiomyopathy.
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiomyopathies; Female; Heart Failure; Heart Ra | 1981 |
Hydralazine tachycardia and sympathetic cardiovascular reactivity in normal subjects.
Topics: Acetylation; Adolescent; Adult; Blood Pressure; Female; Heart Rate; Humans; Hydralazine; Male; Refle | 1980 |
Patterns of heart rate responses to hydralazine in normotensive and hypertensive rats.
Topics: Animals; Antihypertensive Agents; Baroreflex; Bradycardia; Female; Heart Rate; Hydralazine; Hyperten | 1996 |
Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
Topics: Angiotensin II; Animals; Blood Pressure; Central Nervous System; Depression, Chemical; Dose-Response | 1975 |
Sinus tachycardis in a hypertensive patient: drug withdrawal phenomenon?
Topics: Arrhythmia, Sinus; Female; Humans; Hydralazine; Hypertension; Middle Aged; Propranolol; Substance Wi | 1977 |
Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Topics: Aged; Coronary Disease; Digitalis Glycosides; Female; Furosemide; Heart Failure; Humans; Hydralazine | 1978 |
Arterial hypertension in infants with hydronephrosis. Report of six cases.
Topics: Blood Pressure; Female; Humans; Hydralazine; Hydronephrosis; Hypertension, Renal; Infant; Infant, Ne | 1977 |
Investigations into a new antiarrhythmic substance Z-2-amino-5-chlor-benzophenon-amidin-hydralazin in humans.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Humans; Hydralazine; Injections, Intravenous; Intestin | 1992 |
Role of the sympatho-adrenal system in the reflex tachycardia produced by hydralazine in the anesthetized rat.
Topics: Adrenal Glands; Adrenal Medulla; Anesthesia; Animals; Atropine; Blood Pressure; Heart Rate; Hydralaz | 1986 |
Current concepts in sick sinus syndrome. II. ECG manifestation and diagnostic and therapeutic approaches.
Topics: Atrial Fibrillation; Atropine; Bradycardia; Cardiac Pacing, Artificial; Electric Stimulation; Electr | 1985 |
[General principles of antihypertensive treatment].
Topics: Antihypertensive Agents; Cardiac Output; Clonidine; Follow-Up Studies; Ganglionic Blockers; Guanethi | 1974 |
Mechanism of tachycardia induced by intracerebroventricular injection of hydrallazine (1-hydrazinophthalazine).
Topics: Animals; Blood Pressure; Carotid Sinus; Cordotomy; Denervation; Dogs; Electrocardiography; Heart; He | 1965 |
[Absence of direct effect of hydralazine on the heart rate].
Topics: Animals; Dogs; Electrocardiography; Heart Rate; Hydralazine; Injections, Intra-Arterial; Tachycardia | 1968 |